Chronic endometritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with chronic endometritis diagnosed as CD138 positive in the proliferative phase of menstrual cycle; 2.premenopausal women; 3.agree to undergo hysteroscopy, hysteroscopic resection, and endometrial biopsy; 4.no severe systemic diseases; 5.no other antibiotic treatment was received within 1 month before the drug was used in this clinical trial; 6.no contraindications to antibiotic; 7.written informed consent.
Exclusion criteria
Exclusion criteria: 1.Reproductive tract infection; 2.endometrial hyperplasia and (or) endometrial carcinoma; 3.positive result on pregnancy test; 4.acute uterine bleeding; 5.use of hormone replacement therapy or hormonal therapy in the preceding 3 months;6.do not understand or approve this randomized controlled trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| syndecan-1 (CD138); | — |
Countries
China
Contacts
Affiliated Hospital of North Sichuan Medical College